This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Oct 12;355(15):1604-6.

doi: 10.1056/NEJMe068163.

Alzheimer's disease--clinical trials and the logic of clinical purpose

Jason Karlawish

PMID: 17035654
DOI: 10.1056/NEJMe068163

Editorial

Alzheimer's disease--clinical trials and the logic of clinical purpose

Jason Karlawish. N Engl J Med. 2006.

. 2006 Oct 12;355(15):1604-6.

doi: 10.1056/NEJMe068163.

Author

Jason Karlawish

PMID: 17035654
DOI: 10.1056/NEJMe068163

No abstract available

PubMed Disclaimer

Comment in

Atypical antipsychotic drugs and Alzheimer's disease.
Hussain HM, Hotopf M, Oyebode F. Hussain HM, et al. N Engl J Med. 2007 Jan 25;356(4):416; author reply 417-8. doi: 10.1056/NEJMc063094. N Engl J Med. 2007. Retraction in: N Engl J Med. 2007 Apr 5;356(14):1481. doi: 10.1056/NEJMc076105. PMID: 17251541 Retracted. No abstract available.

Comment on

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA; CATIE-AD Study Group. Schneider LS, et al. N Engl J Med. 2006 Oct 12;355(15):1525-38. doi: 10.1056/NEJMoa061240. N Engl J Med. 2006. PMID: 17035647 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information